Certara, Inc. (CERT) Soars 6.1%: Is Further Upside Left in the Stock?Zacks Investment Research • 03/17/22
Certara, Inc. (CERT) CEO William Feehery on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 03/02/22
Certara Customers Received 90 Percent of US FDA Novel Drug Approvals for 8th Consecutive YearGlobeNewsWire • 02/15/22
Certara to Report Fourth Quarter and Full Year 2021 Financial Results on March 1st, 2022GlobeNewsWire • 02/08/22
Can Certara, Inc. (CERT) Climb 35% to Reach the Level Wall Street Analysts Expect?Zacks Investment Research • 01/04/22
Certara Announces FDA Renewal and Expansion of Certara's Biosimulation Software for Reviewing Regulatory SubmissionsGlobeNewsWire • 12/21/21
Certara Announces Release of Simcyp™ Simulator Version 21, Expanding Capabilities to Align with Recent Regulatory GuidancesGlobeNewsWire • 12/02/21
Certara Inc. (CERT) CEO William Feehery on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 11/10/21
Certara to Participate in Piper Sandler 33rd Annual Virtual Healthcare ConferenceGlobeNewsWire • 11/03/21